Independent. Trusted. Proven.
Expert buy, hold and sell recommendations from our team of analysts.
US stocks were mainly in the red and I suspect the reason why won't surprise you. You see, this week there were several revelations for Donald Trump that would have made him see red and encouraged him to take actions that equity markets don’t like.
Peter Switzer is back in the building! He's joined by Paul Rickard to talk Charter Hall, Aristocrat Leisure, and BHP's spot in the group of big Aussie miners.
Two Exchange Traded Funds designed to help conservative investors sleep easier.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains that after trading sideways earlier this month, Beach Energy (BPT) has finally broken out of its consolidation period and this is a buy signal.
Is Aristocrat Leisure, which has been a top performer, in the buy zone? Although our super balances are individually less than $3m but more than $3m in aggregate, if my spouse dies, will I have to pay the new super tax? Do you think President Trump has a plan? Is APA a buy at over $8.00?
Markets are swinging wildly on every Trump tax, tariff and tirade. We ask our most seasoned investors how they're trading through it. Here's how to deal with the tariff shocks, growth stock risks and global volatility.
While Trump’s new curve ball raises questions about which investments make sense, there are good reasons for thinking about adding emerging market ETFs to your portfolio.
If your super balance is $3 million or more, there’s a high chance of paying more tax next year. There are strategies that can be employed to mitigate the impact of this new tax. Below are five tips but before that, I’ve done a review of how the tax will work in practice.
In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk at Morgans, explains why Dalrymple Bay Infrastructure (DBI) retains an ADD rating from Morgans and a $4.35 a share price target.
Cancer is one of the most interesting areas of work of the ASX’s growing cohort of life sciences companies. Here are three of the fascinating stories emerging from this area.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.